NURCHI, VALERIA MARINA
 Distribuzione geografica
Continente #
EU - Europa 241.651
NA - Nord America 14.162
AS - Asia 5.010
SA - Sud America 834
AF - Africa 118
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 6
Totale 261.804
Nazione #
IT - Italia 237.046
US - Stati Uniti d'America 13.975
SG - Singapore 2.011
CN - Cina 2.005
UA - Ucraina 1.146
NL - Olanda 1.098
SE - Svezia 797
BR - Brasile 703
DE - Germania 485
GB - Regno Unito 341
FI - Finlandia 305
VN - Vietnam 269
KR - Corea 168
CA - Canada 129
FR - Francia 119
IN - India 110
HK - Hong Kong 65
RU - Federazione Russa 65
TR - Turchia 54
IR - Iran 53
PL - Polonia 48
IQ - Iraq 45
MX - Messico 45
ZA - Sudafrica 42
AR - Argentina 41
ES - Italia 39
JP - Giappone 39
BD - Bangladesh 34
BE - Belgio 27
EC - Ecuador 26
AT - Austria 25
UZ - Uzbekistan 25
AU - Australia 21
ID - Indonesia 21
IE - Irlanda 17
EG - Egitto 16
PK - Pakistan 16
UY - Uruguay 16
CH - Svizzera 15
MA - Marocco 13
TN - Tunisia 13
CO - Colombia 12
LY - Libia 11
MY - Malesia 11
CZ - Repubblica Ceca 10
TH - Thailandia 10
VE - Venezuela 10
IL - Israele 9
PE - Perù 9
CL - Cile 8
GR - Grecia 8
RO - Romania 8
KE - Kenya 7
SA - Arabia Saudita 7
DK - Danimarca 6
LT - Lituania 6
PY - Paraguay 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
DZ - Algeria 5
PH - Filippine 5
PT - Portogallo 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
AM - Armenia 4
AZ - Azerbaigian 4
EU - Europa 4
HU - Ungheria 4
JM - Giamaica 4
JO - Giordania 4
NG - Nigeria 4
NP - Nepal 4
BY - Bielorussia 3
LK - Sri Lanka 3
PS - Palestinian Territory 3
SN - Senegal 3
AL - Albania 2
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
BS - Bahamas 2
EE - Estonia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MN - Mongolia 2
MU - Mauritius 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
IS - Islanda 1
Totale 261.793
Città #
Cagliari 232.382
Uta 3.910
Fairfield 1.695
Woodbridge 1.283
Ashburn 1.140
Amsterdam 1.070
Houston 874
Chandler 832
Singapore 791
Dallas 723
Wilmington 695
Ann Arbor 688
Boardman 652
Seattle 626
Jacksonville 618
Cambridge 588
Nyköping 573
Beijing 382
Dearborn 338
Los Angeles 206
Nanjing 193
Boston 189
Santa Clara 166
Hefei 161
Seoul 153
Helsinki 122
The Dalles 122
New York 121
Buffalo 120
Shanghai 117
San Diego 93
Ho Chi Minh City 82
Escalaplano 79
Nanchang 71
Redwood City 70
Guangzhou 65
São Paulo 64
Shenyang 61
Dong Ket 60
Hebei 57
Hong Kong 54
London 51
Mountain View 51
Milan 50
Changsha 48
Tianjin 48
Toronto 48
Hanoi 46
Redondo Beach 46
Jiaxing 39
Atlanta 38
Verona 37
Chicago 35
Council Bluffs 34
Norwalk 32
Ottawa 32
Sassari 32
Zhengzhou 30
Jinan 26
Orange 26
Rio de Janeiro 26
Tokyo 25
Warsaw 25
Brussels 24
Baghdad 23
Tashkent 23
Brooklyn 22
Columbus 22
Nuremberg 22
San Jose 22
Hangzhou 20
Pune 20
Auburn Hills 18
Ningbo 18
Phoenix 18
Pars 16
Chennai 15
Falls Church 15
Johannesburg 15
Wuhan 15
Dublin 14
Istanbul 14
Paris 14
Rome 14
Belo Horizonte 13
Da Nang 13
Dhaka 13
Kilburn 13
Montreal 13
Pretoria 13
San Francisco 13
Turku 13
Brasília 12
Charlotte 12
Munich 12
Campinas 11
Curitiba 11
Frankfurt am Main 11
Fuzhou 11
Las Vegas 11
Totale 253.690
Nome #
Iron Chelation for Iron Overload in Thalassemia 5.703
A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity 3.810
Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one 3.596
Complex formation equilibria of Cu2 + and Zn2 + with Irbesartan and Losartan 3.516
para-Aminosalicylic acid in the treatment of manganese toxicity. Complexation of Mn2+ with 4-amino-2-hydroxybenzoic acid and its N-acetylated metabolite 3.484
Multiple Sclerosis and environmental factors. 3.253
Gold - Old drug with new potentials 3.178
Simple solid-phase spectrophotometric method for free iron(III) determination 3.039
Metal coordination and tyrosinase inhibition studies with Kojic-βAla-Kojic 2.906
Searching for new aluminium chelating agents: a family of hydroxypyrone ligands 2.754
Salicylamide derivatives for iron and aluminium sequestration. From synthesis to complexation studies 2.716
The essential metals for humans: a brief overview 2.663
Assessment, validation and application to real samples of an RP-HPLC method for the determination of Guayulins A, B, C and D in Guayule Shrub 2.622
Looking at new ligands for chelation therapy 2.513
Sorption of ofloxacin and chrysodine by grape stalk. A representative case of biomass removal of emerging pollutants from wastewater 2.502
Depleted uranium and human health 2.423
A new tripodal-3-hydroxy-4-pyridinone for iron and aluminium sequestration: synthesis, complexation and in vivo studies 2.398
Copper-Induced Epigenetic Changes Shape the Clinical Phenotype in Wilson's Disease 2.385
A new tripodal kojic acid derivative for iron sequestration: Synthesis, protonation, complex formation studies with Fe3+, Al3+, Cu2+ and Zn2+, and in vivo bioassays 2.376
Kojic acid derivatives as powerful chelators for iron(III) and aluminium(III) 2.263
Gold nanoparticles: A new golden Era in oncology? 2.234
Metal self-assembly mimosine peptides with enhanced antimicrobial activity: towards a new generation of multitasking chelating agentsts 2.204
Iron(III) and aluminum(III) complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectives 2.199
Chelating principles in Menkes and Wilson diseases: Choosing the right compounds in the right combinations at the right time 2.192
A review on coordination properties of thiol-containing chelating agents towards mercury, cadmium, and lead 2.181
New insights into the protogenic and spectroscopic properties of commercial tannic acid: the role of gallic acid impurities 2.178
Do anti-diabetic drugs act as copper ligands? 2.166
Free fluoride determination in honey by ion-specific electrode potentiometry: method assessment, validation and application to real unifloral samples 2.152
Toxicity of nanoparticles: etiology and mechanisms 2.132
New strong extrafunctionalizable tris(3,4-HP) and bis(3,4-HP) metal sequestering agents: synthesis, solution and in vivo metal chelation 2.072
Equilibrium studies of new bis-hydroxypyrone derivatives with Fe3+, Al3+, Cu2+ and Zn2+ 2.034
Tungsten or wolfram: Friend or foe? 2.023
Arsenic toxicity: Molecular targets and therapeutic agents 2.020
Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators 2.012
Complex formation equilibria of polyamine ligands with copper(II) and zinc(II) 1.967
Chelation therapy for metal intoxication. Comments from a thermodynamic view point 1.947
Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds 1.937
Editorial: Applications of Medicinal Bioinorganic Chemistry 1.917
Kill or cure: Misuse of chelation therapy for human diseases 1.901
The meaning of aluminium exposure on human health and aluminium-related diseases 1.889
A portable, disposable, and low-cost optode for sulphide and thiol detection 1.874
Substituent effects on ionization constants as a predictive tool of coordinating ability 1.863
A new hydroxypyrone powerful chelator. From synthesis to AlIII, FeIII, CuII and ZnII complex formation equilibria, and structural characterization 1.857
Silver coordination compounds: A new horizon in medicine 1.836
Alarming use of chelation therapy 1.824
Inexpensive Alizarin Red S-based optical device for the simultaneous detection of Fe(III) and Al(III) 1.819
Chemical features of in use and in progress chelators for iron overload 1.807
Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one, with Al(III), Cu(II) and Zn(II) ions 1.803
Iron III and aluminium III complexes with substituted salicyl-aldehydes and salicylic acids 1.794
Oxovanadium(IV) coordination compounds with kojic acid derivatives in aqueous solution 1.772
(5-Hydroxy-4-oxo-4H-pyran-2-yl)methyl3-({[(5-hydroxy-4-oxo-4H-pyran-2-yl)methoxy] carbonyl}amino) propanoate. Synthesis and its complex formation study 1.769
State of art in chelating agents for the clinical treatment of metal poisoning 1.769
Comparison of selectivity of a family of chelating agents for trivalent (Al3+, Fe3+) and bivalent (Cu2+, Zn2+) metal ions 1.763
An NMR study on the 6,6'-(2-(diethylamino)ethylazanediyl)bis(methylene)bis(5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) interaction with Al(III) and Zn(II) ions 1.750
Biomonitoring of toxic element exposure by ICP-AES and ICP-MS analysis 1.732
Hydroxypyrones, an intriguing family of chelating agents for Fe(III) and Al(III) 1.730
5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one molecule as an intriguing tool in coordination and enzymatic studies 1.725
Noble metals in medicine: Latest advances 1.714
A speciation study on the perturbing effects of iron chelators on the homeostasis of essential metal ions 1.700
null 1.693
Chelating agents as therapeutic compounds - Basic principles 1.689
Unusual PLS application for Pd(ii) sensing in extremely acidic solutions 1.687
A family of hydroxypyrone ligands designed and synthesized for iron chelators 1.679
Sorption of chrysoidine by row cork and cork entrapped in calcium alginate beads 1.652
Uneven hepatic iron and phosphorus distribution in b-thalassemia 1.631
Medical uses of silver: history, myths and scientific evidence 1.621
The Role of Magnesium in Pregnancy and in Fetal Programming of Adult Diseases 1.613
Losartan: a low water soluble oral drug with Cu(II) and Zn(II) coordination properties 1.589
Competition between Cd(II) and other divalent transition metal ions during complex formation with amino acids, peptides, and chelating agents 1.585
Uneven hepatic copper distribution in Wilson's disease 1.581
Chelating agents for human diseases related to aluminium overload 1.541
Synthesis and Mass Spectrometry Analysis of Mimosine-Containing Peptides 1.521
Trace elements and the carotid plaque: the GOOD (Mg, Zn, Se), the UGLY (Fe, Cu), and the BAD (P, Ca)? 1.507
Iron and other metals in the pathogenesis of Parkinson's disease: Toxic effects and possible detoxification 1.497
Uneven cardiac iron distribution in beta-thalassemia 1.491
Biomass against emerging pollution in wastewatee 1.454
Medicinal bio-inorganic chemistry: papers from the Third International Summer School of Bioinorganic Medicinal Chemistry, Cagliari, Italy 1.403
Toxicity of nanoparticles 1.367
Optimization of a newly established gas-chromatographic method for determining lactose and galactose traces: Application to Pecorino Romano cheese 1.363
Development of a sensor for trivalent iron: AHP fixed on mesoporous silica 1.296
Copper(II) and Nickel(II) uptake from aqueous solutions by cork wastes: a NMR and potentiometric study 1.289
Chelating agents for metal intoxication 1.278
The Potential Clinical Properties of Magnesium 1.255
Biomass against emerging pollution in wastewater: Ability of cork for the removal of ofloxacin from aqueous solutions at different pH 1.232
Molecular recognition between adenine or 2,6-diaminopurine and copper(II) chelates with N,O2,S-tripodal tetradentate chelators having thioether or disulfide donor groups. 1.218
Metal ion toxicity 1.217
Deferoxamine-paper for iron(III) and vanadium(V) sensing 1.214
Analytical determination of total acidity in some Sardinian wines: evaluation of the contribute of different acids 1.212
Iron chelating agents for iron overload diseases 1.209
null 1.188
Warns against unapproved ‘chelation therapy’ 1.168
Substituent effects on ionisation and 13C NMR properties of some monosubstituted phenols. A potentiometric, spectrophotometric and 13C NMR study 1.133
Medical therapy of patients contaminated with radioactive cesium or iodine 1.129
Metal ions in the pathogenesis of Alzheimer’s disease: an open field 1.124
Thermodynamic Study of Oxidovanadium(IV) with Kojic Acid Derivatives: A Multi-Technique Approach 1.119
null 1.075
The aging kidney—as influenced by heavy metal exposure and selenium supplementation 1.065
Substituent effect on the stability of iron(III)-salicylate complexes. Structure of trans-[Fe(H5Nsal) 2(H2O)2]Cl·2H2O 1.047
Acidity and Structure of Fluoroquinolone Antibacterials 1.035
Potentiometric and spectrophotometric equilibrium study on Fe(III) and new catechol-bisphosphonate conjugates 1.032
Totale 191.057
Categoria #
all - tutte 344.575
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 344.575


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202127.805 0 0 0 0 0 7.726 5.866 4.034 1.579 3.471 2.941 2.188
2021/202212.527 1.465 1.310 696 960 1.077 949 652 479 891 1.213 1.478 1.357
2022/202317.894 1.410 1.911 2.066 1.412 1.487 2.109 997 2.372 1.204 920 1.158 848
2023/202419.038 1.041 839 846 1.302 2.034 3.370 2.863 1.276 726 1.437 1.687 1.617
2024/202541.563 10.259 11.022 4.737 3.838 2.235 2.611 3.586 261 510 1.530 404 570
2025/20265.149 754 497 1.452 896 657 893 0 0 0 0 0 0
Totale 262.376